In BriefSCI COMMUN

News at a glance

See allHide authors and affiliations

Science  06 Dec 2019:
Vol. 366, Issue 6470, pp. 1174-1175
DOI: 10.1126/science.366.6470.1174

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

In science news around the world, the U.S. Food and Drug Administration approves the first therapy designed to target the root cause of sickle cell disease, an often fatal blood disorder that afflicts about 100,000 Americans. Members of the Society for American Archaeology vote to allow its board to bar attendees who have committed sexual harassment or other misconduct from society events. The United Kingdom's government proposes requiring businesses and agencies that use artificial intelligence to help predict health outcomes and make other decisions to explain how their technology functions to individuals affected by it. Publishing giant Elsevier signs two new "transformative" deals, with Carnegie Mellon University in Pittsburgh, Pennsylvania, and Sweden's Bibsam Consortium, allowing researchers to read its journals and publish in subscription ones on an open-access basis; it is Elsevier's first such deal with a U.S. university. From 2010 to 2017, mortality rates among 24- to 64-year-olds increased in 48 U.S. states, researchers report.

View Full Text

Stay Connected to Science